Daewoong Pharmaceutical's Envlo to enter the global market in full swing with filing for product license in three ASEAN countries
- Written by PR Newswire
![]() |
- Submitted an NDA to Indonesia, Philippines and Thailand
- Signed the export contract in Brazil and Mexico in last February
- Aiming to enter 50 countries by 2030
SEOUL, South Korea, March 22, 2023 /PRNewswire/ -- Daewoong Pharmaceutical began the advance into the global market in full swing with their national new diabetes drug, Envlo (ingredient:...















